NAD-5113

Case Number
5113
Type
Compliance
Challenger
CRN
Advertiser
Quten Research Institute
Product
Qunol CoQ10
Supplement Category
Blood Sugar Health
Date of Decision
Examples of Claims
Medically Proven Efficacy
Taking Qunol reduces both systolic and diastolic pressure by 10% over an 8 week period.
This reduces the risk of heart disease, stroke, kidney disease and dementia.
Supplement Category (NEW)
Type (NEW)
Referred to Government Agency (new)